These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 9359807)

  • 61. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists.
    Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC
    Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Melanocytic naevus or malignant melanoma? A large-scale epidemiological study of diagnostic accuracy.
    Lindelöf B; Hedblad MA; Sigurgeirsson B
    Acta Derm Venereol; 1998 Jul; 78(4):284-8. PubMed ID: 9689297
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preliminary experience with high-dose cisplatin, reduced glutathione and natural interferon-alpha in dacarbazine-resistant malignant melanoma.
    Bajetta E; Rimassa L; Carnaghi C; Del Vecchio M; Celio L; Cassata A
    Tumori; 1998; 84(1):48-51. PubMed ID: 9619714
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro.
    Auzenne E; Leroux ME; Hu M; Pollock RE; Feig B; Klostergaard J
    Melanoma Res; 1998 Jun; 8(3):227-39. PubMed ID: 9664144
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Modulation of tumor cell motility by plasmin.
    Chikahisa L; Matsuo K; Yamada Y
    Invasion Metastasis; 1997; 17(6):323-33. PubMed ID: 9949291
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Skin tumor risk among atomic-bomb survivors in Japan.
    Ron E; Preston DL; Kishikawa M; Kobuke T; Iseki M; Tokuoka S; Tokunaga M; Mabuchi K
    Cancer Causes Control; 1998 Aug; 9(4):393-401. PubMed ID: 9794171
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The expression of C-myb in human metastatic melanoma cell lines and specimens.
    Walker MJ; Silliman E; Dayton MA; Lang JC
    Anticancer Res; 1998; 18(2A):1129-35. PubMed ID: 9615777
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MMP-2 expression is associated with, but not sufficient for, malignant conversion of murine LTA cells.
    Xuan JW; Tuck AB; Wilson SM; Chin JL; Chambers AF
    Anticancer Res; 1998; 18(2A):743-9. PubMed ID: 9615714
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ex-vivo gene therapy using cytokine-transduced tumor vaccines: molecular and clinical pharmacology.
    Simons JW; Mikhak B
    Semin Oncol; 1998 Dec; 25(6):661-76. PubMed ID: 9865681
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study.
    Wolf P; Quehenberger F; Müllegger R; Stranz B; Kerl H
    Melanoma Res; 1998 Aug; 8(4):370-8. PubMed ID: 9764814
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cytotoxic and anticancer activities of some 1-aryl-2-dimethylaminomethyl-2-propen-1-one hydrochlorides.
    Dimmock JR; Vashishtha SC; Patil SA; Udupa N; Dinesh SB; Devi PU; Kamath R
    Pharmazie; 1998 Oct; 53(10):702-6. PubMed ID: 9812337
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders.
    Arber DA; Tamayo R; Weiss LM
    Hum Pathol; 1998 May; 29(5):498-504. PubMed ID: 9596274
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Survival rate of young patients with malignant choroidal melanoma after conservative treatment].
    Romanowska B; Zygulska-Mach H; Ksiezyk M
    Klin Oczna; 1998; 100(4):211-6. PubMed ID: 9770979
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Therapeutic node dissections in malignant melanoma.
    Karakousis CP
    Ann Surg Oncol; 1998 Sep; 5(6):473-82. PubMed ID: 9754754
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A new pseudo-peptide of Arg-Gly-Asp (RGD) with inhibitory effect on tumor metastasis and enzymatic degradation of extracellular matrix.
    Fujii H; Nishikawa N; Komazawa H; Suzuki M; Kojima M; Itoh I; Obata A; Ayukawa K; Azuma I; Saiki I
    Clin Exp Metastasis; 1998 Jan; 16(1):94-104. PubMed ID: 9502081
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cellular vaccine therapies for cancer.
    Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D
    Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681
    [No Abstract]   [Full Text] [Related]  

  • 77. Bovine lactoferrin and Lactoferricin inhibit tumor metastasis in mice.
    Yoo YC; Watanabe S; Watanabe R; Hata K; Shimazaki K; Azuma I
    Adv Exp Med Biol; 1998; 443():285-91. PubMed ID: 9781371
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of interferon-gamma and tumor necrosis factor-alpha on the expression of ICAM-1 and HLA-DR molecules on cells of a human germ cell neoplasm and their susceptibility to lysis by lymphokine-activated killer cells.
    Eisenthal A; Marder O; Maymon B; Misonzhnik F; Skornick Y; Brazowski E; Czernobilsky B; Walt H; Lifschitz-Mercer B
    Pathobiology; 1998; 66(5):205-8. PubMed ID: 9732234
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cancer cell heparanase activity associated with invasion and metastasis.
    Nicolson GL; Nakajima M; Wakabayashi H; Boyd DD; Diaz D; Irimura T
    Adv Enzyme Regul; 1998; 38():19-32. PubMed ID: 9762344
    [No Abstract]   [Full Text] [Related]  

  • 80. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
    Jimbow K
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.